sq-23377 and Dysgammaglobulinemia

sq-23377 has been researched along with Dysgammaglobulinemia* in 1 studies

Other Studies

1 other study(ies) available for sq-23377 and Dysgammaglobulinemia

ArticleYear
Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.
    Clinical and experimental immunology, 1992, Volume: 87, Issue:3

    Secretion of IgM and IgG in vitro by B cells from patients with common variable immunodeficiency (CVI) has been used to classify the disease into three groups. On stimulation with anti-IgM and IL-2, group A patients' cells fail to secrete IgM or IgG, group B patients' cells secrete no IgG and significantly lower levels of IgM than normal cells, and group C patients' cells produce normal levels of both isotypes. Direct activation of protein kinase C using 12,13-phorbol dibutyrate and ionomycin followed by IL-2 or IL-4 has been reported to induce immunoglobulin secretion by normal human B cells. We therefore attempted to induce B cells from group A and group B CVI patients to secrete IgM and IgG after direct activation of protein kinase C together with IL-2 or IL-4. The data show that the failure of secretion of immunoglobulin by B cells from CVI patients could not be reversed using this approach. This finding suggests that the activation channel involving protein kinase C in B cells from CVI patients is not involved in the defect in cell differentiation.

    Topics: B-Lymphocytes; Cells, Cultured; Dysgammaglobulinemia; Humans; IgG Deficiency; Immunoglobulin G; Immunoglobulin M; Interleukin-2; Interleukin-4; Ionomycin; Lymphocyte Activation; Phorbol 12,13-Dibutyrate; Protein Kinase C

1992